Skip to main content

Cerner Provides Access to De-Identified Patient Data for COVID-19 Research and Vaccine Development

KANSAS CITY, Mo., April 24, 2020 (GLOBE NEWSWIRE) — Cerner Corporation (Nasdaq: CERN), a global health care technology company, is now offering select U.S. health systems and academic research centers complimentary access to critical de-identified COVID-19 patient data to help fight the pandemic. This offering will provide eligible health care researchers free access to Cerner’s COVID-19 data set to support epidemiological studies, clinical trials and medical treatments related to COVID-19, in line with applicable laws and guidelines.
The de-identified patient data secured and stored on Cerner HealtheDataLab™, powered by Amazon Web Services Inc. (AWS), will include COVID-19-related demographics to help track spread and surge, underlying illnesses and chronic conditions, treatments, lab results and clinical complications and outcomes that could help drive important medical decisions. A committee including Cerner associates and industry advisors will review the applications and identify recipients that will benefit from the complimentary offering.“Cerner believes deeply in the power of clinical data to advance global research,” said Donald Trigg, president, Cerner. “The current COVID-19 pandemic compelled our team to develop a strategy to help leading health systems advance the search for critical solutions. When we ultimately move from crisis response to recovery, I am hopeful it will also demonstrate the promise of a ‘learning heath network’ to accelerate the next generation of discovery.”Cerner and AWS’ collaboration continues to focus on making health care better for patients and providers. Last year, Cerner worked to reduce re-admissions to hospitals leveraging de-identified data to help make early determinations of the cause of return hospitalizations using AWS services.“This is a pivotal moment in time when having access to the right information at the right time can help save lives,” Shez Partovi, MD, director of Worldwide Business Development for Healthcare, Life Sciences, and Genomics, Amazon Web Services, Inc. “By supporting complimentary access to Cerner HealtheDataLab there is an opportunity to bring health systems, academic medical centers and technology efforts together to securely share information and approaches to better understand, combat and contain COVID-19.”Prior to COVID-19, Cerner began working with research institutions to help clinicians more easily and efficiently gain health insights and guide care. Last year, Cerner announced the development of the Cerner Learning Health NetworkSM , piloting the program with Duke Clinical Research Institute. This work helps automate data collection from multiple sources, including the electronic health record (EHR), to rapidly give medical researchers secure and compliant access to important information that has the potential to transform patient care.Amid COVID-19, Cerner has taken steps to enhance and introduce new technology offerings and recommendations to support health systems as they fight the pandemic, waive license fees for expansion of hospital beds, establish new dashboards designed to summarize and display trends, among other community support efforts globally. Cerner has also launched a dedicated resource site giving clients access to new and updated offerings. More information on clinical research can be accessed at Cerner.com.About Cerner
Cerner’s health technologies connect people and information systems in thousands of contracted provider facilities worldwide dedicated to creating smarter and better care for individuals and communities. Recognized globally for innovation, Cerner assists clinicians in making care decisions and assists organizations in managing the health of their populations. The company also offers an integrated clinical and financial system to help manage day-to-day revenue functions, as well as a wide range of services to support clinical, financial and operational needs, focused on people. For more information, visit Cerner.com, The Cerner Blog or connect on FacebookInstagram, LinkedIn, Twitter or The Cerner Podcast. Nasdaq: CERN. Health care is too important to stay the same.
Media Contacts:
Cerner
Misti Preston, Director of Public Relations, MediaRelations@cerner.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.